Pathophysiology and Management of Heart Failure in Repaired Congenital Heart Disease

Heart Failure Clinics

Volumn 6, Issue 4, 2010, Pages 497-506

  Kantor, Paul F ^a   Redington, Andrew N ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Congenital heart disease; Fontan; Heart failure; Remodeling; Right ventricle

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIAC RESYNCHRONIZATION THERAPY; CHILD; CONGENITAL HEART DISEASE; DIASTOLIC HEART FAILURE; DISEASE COURSE; FONTAN PROCEDURE; HEART FAILURE; HEART SINGLE VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; PATHOPHYSIOLOGY; PEDIATRIC CARDIOLOGY; PHENOTYPE; PROGNOSIS; REOPERATION; REVIEW; SURVIVOR;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOTONIC AGENTS; CHILD; DIASTOLE; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; PROGNOSIS; TRANSPOSITION OF GREAT VESSELS; TREATMENT FAILURE; VENTRICULAR DYSFUNCTION;

EID: 77956921306     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2010.06.002     Document Type: Review

References (45)

1. Verheugt C.L., Uiterwaal C.S., Grobbee D.E., et al. Long-term prognosis of congenital heart defects: a systematic review. Int J Cardiol 2008, 131(1):25-32. [Review].
2. Norozi K., Wessel A., Alpers V., et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol 2006, 97(8):1238-1243. [Research Support, Non-U.S. Gov't].
3. Altmann K., Printz B.F., Solowiejczky D.E., et al. Two-dimensional echocardiographic assessment of right ventricular function as a predictor of outcome in hypoplastic left heart syndrome. Am J Cardiol 2000, 86(9):964-968.
4. Kanter K.R., Forbess J.M., Fyfe D.A., et al. De Vega tricuspid annuloplasty for systemic tricuspid regurgitation in children with univentricular physiology. J Heart Valve Dis 2004, 13(1):86-90.
5. Shaddy R.E., Boucek M.M., Hsu D.T., et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007, 298(10):1171-1179. [see comment], [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't].
6. Fontan F., Baudet E. Surgical repair of tricuspid atresia. Thorax 1971, 26(3):240-248.
7. Khairy P., Fernandes S.M., Mayer J.E., et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008, 117(1):85-92. [see comment], [Research Support, Non-U.S. Gov't].
8. Kim S.J., Kim W.H., Lim H.G., et al. Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg 2008, 136(1):108-116. [Evaluation Studies].
9. Freedom R.M., Yoo S.J., Mikailian H., et al. The natural and modified history of congenital heart disease 2004, 457-459. Blackwell Publishing, Elmsford (NY). R.M. Freedom, S.J. Yoo, H. Mikailian (Eds.).
10. Gewillig M. The Fontan circulation. Heart 2005, 91(6):839-846. [Review].
11. Anderson P.A., Sleeper L.A., Mahony L., et al. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 2008, 52(2):85-98. [see comment], [Multicenter Study Research Support, N.I.H., Extramural].
12. Robbers-Visser D., Kapusta L., van Osch-Gevers L., et al. Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years. J Thorac Cardiovasc Surg 2009, 138(1):89-95.
13. Brassard P., Bedard E., Jobin J., et al. Exercise capacity and impact of exercise training in patients after a Fontan procedure: a review. Can J Cardiol 2006, 22(6):489-495. [Research Support, Non-U.S. Gov't Review].
14. Law Y.M., Ettedgui J., Beerman L., et al. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol 2006, 98(4):520-524. [Comparative Study].
15. Samanek M., Voriskova M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study. Pediatr Cardiol 1999, 20(6):411-417. [Research Support, Non-U.S. Gov't].
16. Huhta J.C., Danielson G.K., Ritter D.G., et al. Survival in atrioventricular discordance. Pediatr Cardiol 1985, 6(2):57-60. [Research Support, U.S. Gov't, P.H.S.].
17. Prieto L.R., Hordof A.J., Secic M., et al. Progressive tricuspid valve disease in patients with congenitally corrected transposition of the great arteries. Circulation 1998, 98(10):997-1005.
18. Fyler D.C. Nadas' pediatric cardiology 1992, Mosby: Mosby Year-Book, St Louis (MO), 701-8.
19. Mavroudis C., Backer C.L. Physiologic versus anatomic repair of congenitally corrected transposition of the great arteries. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2003, 6:16-26. [Comparative Study Review].
20. Alghamdi A.A., McCrindle B.W., Van Arsdell G.S. Physiologic versus anatomic repair of congenitally corrected transposition of the great arteries: meta-analysis of individual patient data. Ann Thorac Surg 2006, 81(4):1529-1535. [Comparative Study Meta-Analysis].
21. Horer J., Schreiber C., Krane S., et al. Outcome after surgical repair/palliation of congenitally corrected transposition of the great arteries. Thorac Cardiovasc Surg 2008, 56(7):391-397. [Comparative Study].
22. Rutledge J.M., Nihill M.R., Fraser C.D., et al. Outcome of 121 patients with congenitally corrected transposition of the great arteries. Pediatr Cardiol 2002, 23(2):137-145.
23. Szymanski P., Klisiewicz A., Lubiszewska B., et al. Application of classic heart failure definitions of asymptomatic and symptomatic ventricular dysfunction and heart failure symptoms with preserved ejection fraction to patients with systemic right ventricles. Am J Cardiol 2009, 104(3):414-418.
24. Winlaw D.S., McGuirk S.P., Balmer C., et al. Intention-to-treat analysis of pulmonary artery banding in conditions with a morphological right ventricle in the systemic circulation with a view to anatomic biventricular repair. Circulation 2005, 111(4):405-411. [Evaluation Studies].
25. Quinn D.W., McGuirk S.P., Metha C., et al. The morphologic left ventricle that requires training by means of pulmonary artery banding before the double-switch procedure for congenitally corrected transposition of the great arteries is at risk of late dysfunction. J Thorac Cardiovasc Surg 2008, 135(5):1137-1144. [Comparative Study].
26. Giardini A., Napoleone C.P., Specchia S., et al. Conversion of atriopulmonary Fontan to extracardiac total cavopulmonary connection improves cardiopulmonary function. Int J Cardiol 2006, 113(3):341-344.
27. Winter M.M., Bouma B.J., Groenink M., et al. Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart 2009, 95(12):960-963. [Comparative Study Research Support, Non-U.S. Gov't Review].
28. Dore A., Houde C., Chan K.L., et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation 2005, 112(16):2411-2416. [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't].
29. Brecker S.J., Xiao H.B., Sparrow J., et al. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992, 340(8831):1308-1312. [see comment][erratum appears in Lancet 1992 Dec 12;340(8833):1482], [Research Support, Non-U.S. Gov't].
30. Blanc J.J., Etienne Y., Gilard M., et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 1997, 96(10):3273-3277. [Clinical Trial Comparative Study].
31. Vogel M., Sponring J., Cullen S., et al. Regional wall motion and abnormalities of electrical depolarization and repolarization in patients after surgical repair of tetralogy of Fallot. Circulation 2001, 103(12):1669-1673. [Clinical Trial Controlled Clinical Trial Research Support, Non-U.S. Gov't].
32. D'Andrea A., Caso P., Sarubbi B., et al. Right ventricular myocardial activation delay in adult patients with right bundle branch block late after repair of Tetralogy of Fallot. Eur J Echocardiogr 2004, 5(2):123-131. [see comment], [Comparative Study Evaluation Studies Research Support, Non-U.S. Gov't].
33. Uebing A., Gibson D.G., Babu-Narayan S.V., et al. Right ventricular mechanics and QRS duration in patients with repaired tetralogy of Fallot: implications of infundibular disease. Circulation 2007, 116(14):1532-1539. [see comment], [Research Support, Non-U.S. Gov't].
34. Gatzoulis M.A., Till J.A., Somerville J., et al. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995, 92(2):231-237. [see comment].
35. Dubin A.M., Janousek J., Rhee E., et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005, 46(12):2277-2283. [Evaluation Studies Multicenter Study Research Support, Non-U.S. Gov't].
36. Jauvert G., Rousseau-Paziaud J., Villain E., et al. Effects of cardiac resynchronization therapy on echocardiographic indices, functional capacity, and clinical outcomes of patients with a systemic right ventricle. Europace 2009, 11(2):184-190.
37. Penny D.J., Rigby M.L., Redington A.N. Abnormal patterns of intraventricular flow and diastolic filling after the Fontan operation: evidence for incoordinate ventricular wall motion. Br Heart J 1991, 66(5):375-378. [Research Support, Non-U.S. Gov't].
38. Penny D.J., Redington A.N. Angiographic demonstration of incoordinate motion of the ventricular wall after the Fontan operation. Br Heart J 1991, 66(6):456-459. [Research Support, Non-U.S. Gov't].
39. Fogel M.A., Gupta K.B., Weinberg P.M., et al. Regional wall motion and strain analysis across stages of Fontan reconstruction by magnetic resonance tagging. Am J Physiol 1995, 269(3 Pt 2):H1132-H1152. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
40. Border W.L., Syed A.U., Michelfelder E.C., et al. Impaired systemic ventricular relaxation affects postoperative short-term outcome in Fontan patients. J Thorac Cardiovasc Surg 2003, 126(6):1760-1764.
41. Garofalo C.A., Cabreriza S.E., Quinn T.A., et al. Ventricular diastolic stiffness predicts perioperative morbidity and duration of pleural effusions after the Fontan operation. Circulation 2006, 114(1 Suppl):I56-I61. [Research Support, N.I.H., Extramural].
42. Cheung Y.F., Penny D.J., Redington A.N. Serial assessment of left ventricular diastolic function after Fontan procedure. Heart 2000, 83(4):420-424.
43. Tulevski, van der Wall E.E., Groenink M., et al. Usefulness of magnetic resonance imaging dobutamine stress in asymptomatic and minimally symptomatic patients with decreased cardiac reserve from congenital heart disease (complete and corrected transposition of the great arteries and subpulmonic obstruction). Am J Cardiol 2002, 89(9):1077-1081. [Clinical Trial Controlled Clinical Trial Research Support, Non-U.S. Gov't].
44. Fratz S., Hager A., Busch R., et al. Patients after atrial switch operation for transposition of the great arteries can not increase stroke volume under dobutamine stress as opposed to patients with congenitally corrected transposition. Circ J 2008, 72(7):1130-1135. [Comparative Study].
45. Vogt M., Kuhn A., Wiese J., et al. Reduced contractile reserve of the systemic right ventricle under Dobutamine stress is associated with increased brain natriuretic peptide levels in patients with complete transposition after atrial repair. Eur J Echocardiogr 2009, 10(5):691-694.